Maze Therapeutics Turns Profitable in 2024
Maze Therapeutics reports a profit for the first nine months of 2024, marking a turnaround from last year's losses. Discover the key factors driving this financial shift.
Topic
2024 Financials
A collection of 4 issues
Ford's Strong Sales, Stock Drops 19% in 2024
Ford experiences robust vehicle sales, yet faces a 19% decline in stock value in 2024. Explore the impact on Ford's financial performance.
Turo's 2024 Profit Dips Despite Positive Earnings
Turo's net income hit $19.4M in the first nine months of 2024, with adjusted EBITDA of $47.6M. Discover how these figures compare to 2023's performance.
Alphabet Drives Earnings Growth in 2024
Alphabet plays a key role in the 'Magnificent Seven's' earnings surge for 2024, showcasing its financial strength and market influence.